AcquirerTargetPrice
EQT PartnersPress Ganey$2.35 billion
Carter Validus Mission Critical REIT IIHPI portfolio$116.5 million
Allergan plcForSight VISIONS$95 million
Scintilla PharmaceuticalsSCILEX Pharmaceuticals $70 million
ZymeWorks Inc. License to HuTARG platform$65 million